Breast Cancer Clinical Trial Information (2015.12.03)
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
A Phase 3 clinical trial was conducted for postmenopausal metastatic breast cancer patients with hormone receptor-positive and HER2-positive status. From May 2011 to December 2017, volunteers were recruited in Taiwan, Japan, and the United States, with a target of 525 participants. The drugs used were Tykerb and Chugai Pharmaceutical's Herceptin. For more details about this clinical trial, please refer to the following website:
http://www.clinicaltrials.jp/user/cteDetail.jsp?clinicalTrialId=6431
Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.
Figure 1
Figure 2
Figure 3
Figure 4